Axonics Modulation Technologies, Inc. (AXNX) financial statements (2020 and earlier)

Company profile

Business Address 26 TECHNOLOGY DRIVE
IRVINE, CA 92618
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments18410212614415831
Cash and cash equivalents1717683899820
Short-term investments132543555911
Receivables811100
Inventory, net of allowances, customer advances and progress billings16138542
Inventory16138542
Other undisclosed current assets433342
Total current assets:21211813815316535
Noncurrent Assets
Property, plant and equipment333333
Intangible assets, net (including goodwill)000000
Intangible assets, net (excluding goodwill)000000
Other noncurrent assets555334
Total noncurrent assets:888777
TOTAL ASSETS:22012614615917242
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1197455
Accounts payable643232
Accrued liabilities244223
Employee-related liabilities3     
Debt1742  
Other undisclosed current liabilities   111
Total current liabilities:121611765
Noncurrent Liabilities
Long-term debt and lease obligation25182118199
Long-term debt, excluding current maturities20141618199
Operating lease, liability455 
Other undisclosed noncurrent liabilities   333
Total noncurrent liabilities:251821212313
Total liabilities:373432282918
Temporary equity, carrying amount     113
Stockholders' equity
Stockholders' equity attributable to parent18392114131143(89)
Common stock00000 
Additional paid in capital3632502472452433
Accumulated other comprehensive loss(0)(1)(0)(0)(0)(0)
Accumulated deficit(180)(157)(132)(113)(100)(90)
Stockholders' equity note, subscriptions receivable     (2)
Total stockholders' equity:18392114131143(89)
TOTAL LIABILITIES AND EQUITY:22012614615917242

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
Revenues1011100
Cost of revenue
(Cost of Goods and Services Sold)
(5)(1)(1)(1)(0)(0)
Gross profit:511100
Operating expenses(28)(26)(20)(14)(10)(8)
Operating loss:(23)(25)(19)(14)(9)(8)
Nonoperating income (expense)(0)001(0)(0)
Investment income, nonoperating011110
Other nonoperating expense(1)(1)(1)(1)(1)(0)
Interest and debt expense(0)  (0)  
Other undisclosed loss from continuing operations before equity method investments, income taxes    (0) 
Loss from continuing operations before equity method investments, income taxes:(23)(25)(19)(13)(10)(8)
Other undisclosed income from continuing operations before income taxes0  00 
Loss from continuing operations before income taxes:(23)(25)(19)(13)(10)(8)
Income tax expense  (0)   
Net loss available to common stockholders, diluted:(23)(25)(19)(13)(10)(8)

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
Net loss:(23)(25)(19)(13)(10)(8)
Comprehensive loss:(23)(25)(19)(13)(10)(8)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)(0)(0)(0)(0)
Comprehensive loss, net of tax, attributable to parent:(23)(25)(19)(13)(10)(8)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: